Malin Corporation | MLC - Des Atouts





Des Atouts Changement Date
Akebia Therapeutics USD 349.66M 12.86M 2026-06
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
ALKERMES USD 4.39B 135.05M 2026-06
Avita Medical AUD 56.39M 1.74M 2025-12
Dianthus Therapeutics USD 1.21B 33.61M 2026-06
Eurofins Scientific SE EUR 11.11B 123M 2026-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
IQVIA Holdings USD 29.88B 206M 2026-06
Lonza CHF 18.97B 164M 2025-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Moderna USD 10.96B 527M 2026-06
Organon & Co USD 13.18B 182M 2026-06
Ovoca Bio EUR 2.07M 414K 2025-12
Revvity USD 12.05B 49.24M 2026-06
Tectonic Therapeutic USD 246.58M 14.46M 2026-03
Viatris USD 35.04B 1.79B 2026-06
Xeris Pharmaceuticals USD 411.9M 19.89M 2026-06